Adams VR, Burke TG. Camptothecins in cancer therapy. Berlin/Heidelberg, Germany: Springer; 2005.

Book  Google Scholar 

Alamdari SG, Amini M, Jalilzadeh N, Baradaran B, Mohammadzadeh R, Mokhtarzadeh A, Oroojalian F. Recent advances in nanoparticle-based photothermal therapy for breast cancer. J Control Release. 2022;349:269–303.

Article  CAS  PubMed  Google Scholar 

Alshammari MK, Alshehri MM, Alshehri AM, Alshlali OM, Mahzari AM, Almalki HH, Imran M (2023) Camptothecin loaded nano-delivery systems in the cancer therapeutic domains: A critical examination of the literature. J Drug Delivery Sci Technol 79:104034

Bai S, Ma X, Shi X, Shao J, Zhang T, Wang Y, Cheng Y, Xue P, Kang Y, Xu Z. Smart unimolecular micelle-based polyprodrug with dual-redox stimuli response for tumor microenvironment: enhanced in vivo delivery efficiency and tumor penetration. ACS Appl Mater Interfaces. 2019;11(39):36130–40.

Article  CAS  PubMed  Google Scholar 

Bai S, Jia D, Ma X, Liang M, Xue P, Kang Y, Xu Z. Cylindrical polymer brushes-anisotropic unimolecular micelle drug delivery system for enhancing the effectiveness of chemotherapy. Bioact Mater. 2021;6(9):2894–904.

CAS  PubMed  PubMed Central  Google Scholar 

Barrios CH. Global challenges in breast cancer detection and treatment. Breast. 2022;62:S3–6.

Article  PubMed  PubMed Central  Google Scholar 

Birnbaum JK, Duggan C, Anderson BO, Etzioni R. Early detection and treatment strategies for breast cancer in low-income and upper middle-income countries: a modelling study. Lancet Glob Health. 2018;6(8):e885-93.

Article  PubMed  PubMed Central  Google Scholar 

Bishayee A, Sethi G. Bioactive natural products in cancer prevention and therapy: progress and promise. In: Seminars in cancer biology Vol. 40. Academic Press; 2016. p. 1–3.

Google Scholar 

Brewer HR, Jones ME, Schoemaker MJ, Ashworth A, Swerdlow AJ. Family history and risk of breast cancer: an analysis accounting for family structure. Breast Cancer Res Treat. 2017;165:193–200.

Article  PubMed  PubMed Central  Google Scholar 

Chavda VP, Nalla LV, Balar P, Bezbaruah R, Apostolopoulos V, Singla RK, Khadela A, Vora L, Uversky VN. Advanced phytochemical-based nanocarrier systems for the treatment of breast cancer. Cancers. 2023;15(4):1023.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheema PS, Nandi D, Nag A. Camptothecin exerts anti-cancer effects through FoxM1 Inhibition. Indian J Biochem Biophys (IJBB). 2025;62(3):331–41.

CAS  Google Scholar 

Chen KJ, Tang L, Garcia MA, Wang H, Lu H, Lin WY, Hou S, Yin Q, Shen CKF, Cheng J, Tseng HR. The therapeutic efficacy of camptothecin-encapsulated supramolecular nanoparticles. Biomaterials. 2012;33(4):1162–9.

Article  CAS  PubMed  Google Scholar 

Chen M, Zhang Y, Chen Z, Xie S, Luo X, Li X. Synergistic antitumor efficacy of redox and pH dually responsive micelleplexes for co-delivery of camptothecin and genes. Acta Biomater. 2017;49:444–55.

Article  CAS  PubMed  Google Scholar 

Cheng Z, Cheng Y, Chen Q, Li M, Wang J, Liu H, Li M, Ning Y, Yu Z, Wang Y, Wang H. Self-assembly of pentapeptides into morphology-adaptable nanomedicines for enhanced combinatorial chemo-photodynamic therapy. Nano Today. 2020;33:100878.

Article  CAS  Google Scholar 

Choi KY, Yoon HY, Kim JH, Bae SM, Park RW, Kang YM, Kim IS, Kwon IC, Choi K, Jeong SY, Kim K. Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy. ACS Nano. 2011;5(11):8591–9.

Article  CAS  PubMed  Google Scholar 

CoelinghBennink HJ, Schultz IJ, Schmidt M, Jordan VC, Briggs P, Egberts JF, Gemzell-Danielsson K, Kiesel L, Kluivers K, Krijgh J, Simoncini T. Progesterone from ovulatory menstrual cycles is an important cause of breast cancer. Breast Cancer Res. 2023;25(1):60.

Article  Google Scholar 

Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. The Lancet. 2019;394(10204):1159–68.

Article  Google Scholar 

Dasari N, Guntuku GS, Pindiprolu SKS. Targeting triple negative breast cancer stem cells using nanocarriers. Discover Nano. 2024;19(1):41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fraguas-Sánchez AI, Martín-Sabroso C, Fernández-Carballido A, Torres-Suárez AI. Current status of nanomedicine in the chemotherapy of breast cancer. Cancer Chemother Pharmacol. 2019;84(4):689–706.

Article  PubMed  Google Scholar 

Ghanbari-Movahed M, Kaceli T, Mondal A, Farzaei MH, Bishayee A. Recent advances in improved anticancer efficacies of camptothecin nano-formulations: a systematic review. Biomedicines. 2021;9(5):480.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goldwasser F, Shimizu T, Jackman J, Hoki Y, O’Connor PM, Kohn KW, Pommier Y. Correlations between S and G2 arrest and the cytotoxicity of camptothecin in human colon carcinoma cells. Cancer Res. 1996;56:4430–7.

CAS  PubMed  Google Scholar 

Gunasekera SP, Badawi MM, Cordell GA, Farnsworth NR, Chitnis M. Plant anticancer agents X. isolation of camptothecin and 9-methoxycamptothecin from Ervatamia heyneaya. J Nat Prod. 1979;42:475–7.

Article  CAS  PubMed  Google Scholar 

Hao X, Gai W, Wang L, Zhao J, Sun D, Yang F, Jiang H, Feng Y. 5-Boronopicolinic acid-functionalized polymeric nanoparticles for targeting drug delivery and enhanced tumor therapy. Mater Sci Eng: C. 2021;119:111553.

Article  CAS  Google Scholar 

Hao L, Zhou Q, Piao Y, Zhou Z, Tang J, Shen Y. Albumin-binding prodrugs via reversible iminoboronate forming nanoparticles for cancer drug delivery. J Control Release. 2021;330:362–71.

Article  CAS  PubMed  Google Scholar 

Jain V, Kumar H, Anod HV, Chand P, Gupta NV, Dey S, Kesharwani SS. A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer. J Control Release. 2020;326:628–47.

Article  CAS  PubMed  Google Scholar 

Jeevanandam J, San Chan Y, Danquah MK. Nano-formulations of drugs: recent developments, impact and challenges. Biochimie. 2016;128:99–112.

Article  PubMed  Google Scholar 

Kotsopoulos J, Lubinski J, Lynch HT, Neuhausen SL, Ghadirian P, Isaacs C, Weber B, Kim-Sing C, Foulkes WD, Gershoni-Baruch R, Ainsworth P. Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Cancer Causes Control. 2005;16:667–74.

Article  PubMed  Google Scholar 

Lammert J, Grill S, Kiechle M. Modifiable lifestyle factors: opportunities for (hereditary) breast cancer prevention-a narrative review. Breast Care. 2018;13(2):108–13.

Article  Google Scholar 

Landgraf M, Lahr CA, Kaur I, Shafiee A, Sanchez-Herrero A, Janowicz PW, Ravichandran A, Howard CB, Cifuentes-Rius A, McGovern JA, Voelcker NH. Targeted camptothecin delivery via silicon nanoparticles reduces breast cancer metastasis. Biomaterials. 2020;240:119791.

Article  CAS  PubMed  Google Scholar 

Liu Q, Yang Y, Pan M, Shi K, Mo D, Li Y, Wang M, Guo L, Qian Z. Camptothecin multifunctional nanoparticles effectively achieve a balance between the efficacy of breast cancer treatment and the preservation of intestinal homeostasis. Bioact Mater. 2024;41:413–26.

CAS  PubMed  PubMed Central  Google Scholar 

Liu LF, Desai SD, LI TK, Mao Y, Sun MEI, SIM SP. Mechanism of action of camptothecin. Annal N Y Acad Sci. 2000;922(1):1–10.

Article  CAS  Google Scholar 

Lu Y, Jia D, Ma X, Liang M, Hou S, Qiu W, Gao Y, Xue P, Kang Y, Xu Z. Reduction-responsive chemo-capsule-based prodrug nanogel for synergistic treatment of tumor chemotherapy. ACS Appl Mater Interfaces. 2021;13(7):8940–51.

Article  CAS  PubMed  Google Scholar 

Luo X, Chen M, Zhang Y, Chen Z, Li X. Pharmacokinetics and antitumor efficacy of micelles assembled from multiarmed amphiphilic copolymers with drug conjugates in comparison with drug-encapsulated micelles. Eur J Pharm Biopharm. 2016;98:9–19.

Article  CAS  PubMed  Google Scholar 

Luo X, Chen M, Chen Z, Xie S, He N, Wang T, Li X. An implantable depot capable of in situ generation of micelles to achieve controlled and targeted tumor chemotherapy. Acta Biomater. 2018;67:122–33.